Farallon Capital Management LLC Iveric Bio, Inc. Transaction History

Farallon Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$26.24 - $39.63 $51.4 Million - $77.6 Million	1,957,500 Added 403.78%	2,442,299 $96.1 Million
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $18.2 Million - $24 Million	-977,201 Reduced 66.84%	484,799 $11.8 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $2.5 Million - $3.47 Million	145,000 Added 11.01%	1,462,000 $31.3 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $12.4 Million - $24.5 Million	1,317,000 New	1,317,000 $23.6 Million
Q3 2020 Nov 16, 2020	BUY	$4.01 - $6.29 $19,007 - $29,814	4,740 Added 0.63%	754,740 $4.26 Million

Q2 2020 Aug 14, 2020	BUY	$3.06 - $6.6 $2.3 Million - $4.95 Million	750,000 New	750,000 $3.82 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.